Skip to main content
Equibles

Qube Research & Technologies Ltd

Position in AKBA — Akebia Therapeutics, Inc.

CIK 1729829 LONDON, X0
Back to AKBA Full portfolio

Position in AKBA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,028,865
-$1,300,483 QoQ
Shares Held
1,779,707
-25.7% QoQ
Ownership
0.642%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 170 holders
Holding Since
Jun 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $592,833,307 across 20 Drug Manufacturers - Specialty & Generic names. AKBA ranks #16 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 2,279,333 $163,792,869
2 UTHR
UNITED THERAPEUTICS Corp
 233,639 $126,592,619
3 VTRS
Viatris Inc
 6,180,223 $98,141,941
4 SUPN
Supernus Pharmaceuticals, Inc.
 922,166 $42,889,940
5 TAK
Takeda Pharmaceutical Co Ltd
 2,207,432 $35,385,134
6 XERS
Xeris Biopharma Holdings, Inc.
 2,893,749 $22,918,492
7 KNSA
Kiniksa Pharmaceuticals International, plc
 304,080 $19,445,916
8 ANIP
Ani Pharmaceuticals Inc
 192,945 $15,971,987

All Filings in AKBA

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,028,865 1,779,707
2026-03-31 $3,329,348 2,395,215
2025-12-31 $4,815,134 2,990,767
2025-09-30 $8,752,882 3,206,184
2025-06-30 $6,240,940 1,714,544
2025-03-31 $2,051,091 1,068,277
2024-12-31 $2,263,582 1,191,359
2024-09-30 $1,747,322 1,323,729
2024-06-30 $1,779,507 1,744,616
2024-03-31 $4,140,697 2,262,676
2023-12-31 $318,894 257,173
2023-09-30 $138,414 121,416
2023-06-30 $399,186 436,269
2022-12-31 $8,571 14,855
2022-09-30 $66,282 209,755
2022-06-30 $211,227 598,379
2021-06-30 $157,527 41,564
2020-06-30 $293,545 21,616